Leveraging Real-Time Clinical Data to Deliver Certainty in Formulation Development: Case Studies from Across 300 Delivered Programs - Paris, France

Find out more about how the Translational Pharmaceutics® platform can be used in drug product optimization at our upcoming event.

Drug product optimization is a critical development step common for most drugs that are progressing through today’s development pipelines to respond to suboptimal exposure profiles. 

Drug product optimization is necessary to help transition from an early development formulation to one suitable for chronic administration in patients, or as part of a life-cycle management strategy. Traditional drug product optimization processes take 12-18 months to complete and place significant emphasis on the predictive power of laboratory and preclinical assessments. This approach is a non-optimal working model necessitated by the multiple disciplines required to develop, make, and test new formulations in humans.

In this presentation, Dr. Andrew Parker, Sr. Drug Development Consultant, will describe the application of Quotient Sciences’ Translational Pharmaceutics to re-engineer and streamline the drug product optimization process, using clinical data to improve decision-making and halve development timelines.

You'll learn how Translational Pharmaceutics® is applied to drug product optimization and hear case studies on reformulation programs from our expert.

*We reserve the right, at our sole discretion, to deny registration or remove any individual who is not a confirmed current or potential client/partner of Quotient Sciences.